Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040.
暂无分享，去创建一个
A. El-Khoueiry | J. Neely | F. Tovoli | M. Tschaika | M. Acosta-Rivera | J. Knox | H. Lim | S. Soleymani | B. Sangro | C. Hsu | Y. Kang | Ming-Mo Hou | A.R. He | I. Melero | T. Yau | T-Y. Kim | A. Santoro | M. Kudo | A. Matilla | B. El-Rayes | J. Yao